This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Loading...
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
Curcuma zedoaria var.
Free herbal dosage calculator — adult & child doses by weight.
Temu Putih contains bioactive compounds including germacrone, furanodienones, and zedoarone, which demonstrate anti-inflammatory and immunomodulatory properties in laboratory studies. The essential oils contribute antimicrobial effects that may help the body resist infections. While curcumin content is lower than in common turmeric, the unique sesquiterpenoids in temu putih appear to modulate inflammatory pathways. Evidence level C indicates these mechanisms are primarily supported by preclinical research rather than extensive human trials. Traditional use spans centuries in Indonesian Jamu and Thai medicine for immune support and post-partum recovery.
No, Temu Putih is contraindicated for individuals taking blood-thinning medications such as warfarin, aspirin, or clopidogrel. The rhizome contains compounds that may affect platelet aggregation and increase bleeding risk when combined with anticoagulants. Although the curcumin content is relatively low compared to other Curcuma species, the cumulative effect with blood thinners poses potential safety concerns. Patients on anticoagulant therapy should avoid temu putih supplements and consult their healthcare provider before using any herbal preparations. This interaction is documented in herbal safety guidelines.
The traditional adult dosage of Temu Putih is 2-5 grams of dried rhizome daily, typically prepared as a decoction or incorporated into Jamu formulations. This dosage range is based on traditional Indonesian and Thai medicine practices rather than standardized clinical trials. Fresh rhizome preparations may require slightly higher amounts by weight. Users should start at the lower end of the range to assess tolerance, as higher doses may cause gastrointestinal irritation in sensitive individuals. Standardized extracts may have different dosing recommendations based on concentration.
Temu Putih is considered unsafe during pregnancy and should be strictly avoided by pregnant women. Traditional Indonesian medicine specifically reserves temu putih for post-partum use, not during gestation. The rhizome contains compounds that may stimulate uterine contractions, potentially risking miscarriage or premature labor. Healthcare practitioners advise discontinuing use if pregnancy is suspected or planned. While temu putih has a long history of use in post-partum Jamu formulations to support recovery after childbirth, it is explicitly contraindicated throughout pregnancy. Women who are breastfeeding should also consult a healthcare provider before use.
Temu Putih has been used for centuries in Indonesian Jamu and Thai traditional medicine primarily for immune support, post-partum recovery, and as an anti-inflammatory agent. In Jamu traditions, it is commonly combined with other herbs like temulawak and ginger to create immune-boosting tonics. Post-partum women traditionally use temu putih to help restore strength and reduce inflammation after childbirth. Thai medicine employs it similarly for digestive and immune complaints. Modern interest focuses on its potential anti-inflammatory applications, though clinical evidence remains limited to preliminary studies with Evidence level C.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 1 PubMed articles · model: gemma4:31b
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.